Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance

CONTEXT: Glucagon-like peptide-1 (GLP-1) agonists control postprandial glucose and lipid excursion in type 2 diabetes; however, the mechanisms are unclear. OBJECTIVE: To determine the mechanisms of postprandial lipid and glucose control with lixisenatide (GLP-1 analog) in type 2 diabetes. DESIGN: Ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Whyte, Martin B, Shojaee-Moradie, Fariba, Sharaf, Sharaf E, Jackson, Nicola C, Fielding, Barbara, Hovorka, Roman, Mendis, Jeewaka, Russell-Jones, David, Umpleby, A Margot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2018
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300412/
https://www.ncbi.nlm.nih.gov/pubmed/30215735
http://dx.doi.org/10.1210/jc.2018-01176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300412/
https://www.ncbi.nlm.nih.gov/pubmed/30215735
http://dx.doi.org/10.1210/jc.2018-01176

Ejemplares similares